{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:44:06Z","timestamp":1784735046708,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["01ER1901 PERGOLA2"],"award-info":[{"award-number":["01ER1901 PERGOLA2"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["01ER1901 PERGOLA2"],"award-info":[{"award-number":["01ER1901 PERGOLA2"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["01ER1901 PERGOLA2"],"award-info":[{"award-number":["01ER1901 PERGOLA2"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["01ER1901 PERGOLA2"],"award-info":[{"award-number":["01ER1901 PERGOLA2"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiovascular disease (CVD) is the leading cause of death worldwide. The aim of this study was to examine if CVD affects the mortality of women after a breast cancer diagnosis and population controls differently.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The analysis included a total of 3,555 women, diagnosed with primary stage 1\u20133 breast cancer or in situ carcinoma between 2002 and 2005 and 7,334 controls breast cancer-free at recruitment, all aged 50\u201374\u00a0years, who were followed-up in a German breast cancer case\u2013control study until June, 30 2020. Kaplan\u2013Meier and cumulative incidence function were calculated for all-cause mortality and mortality from any cancer, stratified for case\u2013control status and CVD, separately for women aged\u2009&lt;\u200965 and\u2009\u2265\u200965\u00a0years. Cox regression and Fine-Gray subdistribution hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for the association between case\u2013control-status, CVD and mortality from all causes\/any cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median follow-up was 16.1\u00a0years. In total, 1,172 cases (33.0%) and 1,401 initial controls (19.1%) died. CVD prevalence at recruitment was 15.2% in cases and controls. Cases with CVD had the highest and controls without CVD the lowest mortality during the entire observation period in both age groups (&lt;\u200965 and\u2009\u2265\u200965\u00a0years). CVD was identified as a risk factor for all-cause mortality in both cases and controls aged\u2009&lt;\u200965\u00a0years (HR 1.22, 95%CI 0.96\u20131.55 and HR 1.79, 95%CI 1.43\u20132.24) as well as at ages of\u2009\u2265\u200965\u00a0years (HR 1.44, 95%CI 1.20\u20131.73 and HR 1.59, 95%CI 1.37\u20131.83). A significant association of CVD and cancer mortality was found only for cases aged\u2009\u2265\u200965\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CVD was significantly associated with all-cause mortality of both cases and controls and CVD was identified as a risk factor for cancer mortality of cases aged\u2009\u2265\u200965\u00a0years at recruitment. Therefore, attention should be paid on monitoring and preventing CVD in breast cancer patients, especially in those diagnosed at older ages.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13058-023-01680-x","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T07:02:46Z","timestamp":1690441366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The impact of cardiovascular disease on all-cause and cancer mortality: results from a 16-year follow-up of a German breast cancer case\u2013control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Annika","family":"M\u00f6hl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Fla\u00dfkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Kreienbrinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Gali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chang-Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"1680_CR1","unstructured":"World health organization: Cancer. Fact sheet no. 297 https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cancer (2022). Assessed 15.12.2022."},{"key":"1680_CR2","doi-asserted-by":"publisher","first-page":"c3620","DOI":"10.1136\/bmj.c3620","volume":"341","author":"P Autier","year":"2010","unstructured":"Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, H\u00e9ry C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (Clin Res Ed). 2010;341:c3620.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1680_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2017.06.003","volume":"36","author":"G Carioli","year":"2017","unstructured":"Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. The Breast. 2017;36:89\u201395.","journal-title":"The Breast"},{"key":"1680_CR4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205\u201340.","journal-title":"Br J Cancer"},{"key":"1680_CR5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMoa1000727","volume":"363","author":"M Kalager","year":"2010","unstructured":"Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:1203\u201310.","journal-title":"N Engl J Med"},{"key":"1680_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.321.7262.665","volume":"321","author":"RG Blanks","year":"2000","unstructured":"Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990\u20138: comparison of observed with predicted mortality. BMJ (Clin Res Ed). 2000;321:665\u20139.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1680_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1470-2045(03)01037-4","volume":"4","author":"I Jatoi","year":"2003","unstructured":"Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol. 2003;4:251\u20134.","journal-title":"Lancet Oncol"},{"key":"1680_CR8","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/1055-9965.EPI-11-0729","volume":"20","author":"C Parry","year":"2011","unstructured":"Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996\u20132005.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1680_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/jnci\/djaa097","volume":"113","author":"AH Blaes","year":"2021","unstructured":"Blaes AH, Konety SH. Cardiovascular disease in breast cancer survivors: an important topic in breast cancer survivorship. J Nat Cancer Inst. 2021;113:105\u20136.","journal-title":"J Nat Cancer Inst"},{"key":"1680_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards BK, Noone A-M, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290\u2013314.","journal-title":"Cancer"},{"key":"1680_CR11","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2901","volume":"13","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, Diguiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13:R64.","journal-title":"Breast Cancer Res"},{"key":"1680_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. New Engl J Med. 2013;368:987\u201398.","journal-title":"New Engl J Med"},{"key":"1680_CR13","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"RJ Koene","year":"2016","unstructured":"Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104\u201314.","journal-title":"Circulation"},{"key":"1680_CR14","unstructured":"Laxmi S. Mehta, MD, FAHA [Chair], Karol E. Watson, MD, PhD, FAHA [Vice Chair], Ana Barac, MD, PhD, Theresa M. Beckie, PhD, FAHA, Vera Bittner, MD, MSPH, FAHA, Salvador Cruz-Flores, MD, MPH, FAHA, Susan Dent, MD, Lavanya Kondapalli, MD, Bonnie Ky, MD, MSCE, Tochukwu Okwuosa, DO, Ileana L. Pi\u00f1a, MD, MPH, FAHA, Annabelle Santos Volgman, MD, FAHA American heart association cardiovascular disease in women and special populations committee of the council on clinical cardiology, council on cardiovascular and stroke nursing, and council on quality of care and outcomes research: cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American heart association. Circulation 2018; 137: e30\u2013e66."},{"key":"1680_CR15","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1200\/JCO.2006.08.0499","volume":"25","author":"EO Hanrahan","year":"2007","unstructured":"Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, et al. Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J Clin Oncol. 2007;25:4952\u201360.","journal-title":"J Clin Oncol"},{"key":"1680_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/EDE.0000000000000394","volume":"27","author":"PT Bradshaw","year":"2016","unstructured":"Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular disease mortality among breast cancer survivors. Epidemiology. 2016;27:6\u201313.","journal-title":"Epidemiology"},{"key":"1680_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jnci\/djaa096","volume":"113","author":"C Ramin","year":"2021","unstructured":"Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, et al. All-cause and cardiovascular disease mortality among breast cancer survivors in clue ii, a long-standing community-based cohort. J Natl Cancer Inst. 2021;113:137\u201345.","journal-title":"J Natl Cancer Inst"},{"key":"1680_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","volume":"164","author":"SAM Gernaat","year":"2017","unstructured":"Gernaat SAM, Ho PJ, Rijnberg N, Emaus MJ, Baak LM, Hartman M, et al. Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164:537\u201355.","journal-title":"Breast Cancer Res Treat"},{"key":"1680_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ijc.23655","volume":"123","author":"D Flesch-Janys","year":"2008","unstructured":"Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008;123:933\u201341.","journal-title":"Int J Cancer"},{"key":"1680_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","volume":"12","author":"BMP Aleman","year":"2014","unstructured":"Aleman BMP, Moser EC, Nuver J, Suter TM, Maraldo MV, Specht L, et al. Cardiovascular disease after cancer therapy. EJC Suppl. 2014;12:18\u201328.","journal-title":"EJC Suppl"},{"key":"1680_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","volume":"110","author":"BJ North","year":"2012","unstructured":"North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110:1097\u2013108.","journal-title":"Circ Res"},{"key":"1680_CR22","first-page":"1887","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019 Int J Epidemiol. 2016;45:1887\u201394.","journal-title":"Int J Epidemiol"},{"key":"1680_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000487261","volume":"13","author":"E Lorenz","year":"2018","unstructured":"Lorenz E, Blettner M, Lange B, Schmidt M, Schneider A, Schwentner L, et al. Prevalence of cardiac disease in breast cancer patients at time of diagnosis compared to the general female population in Germany. Breast Care (Basel). 2018;13:264\u201371.","journal-title":"Breast Care (Basel)"},{"key":"1680_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11764-013-0267-9","volume":"7","author":"KE Weaver","year":"2013","unstructured":"Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7:253\u201361.","journal-title":"J Cancer Surviv"},{"key":"1680_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/tbj.12855","volume":"24","author":"D Wollschl\u00e4ger","year":"2018","unstructured":"Wollschl\u00e4ger D, Meng X, W\u00f6ckel A, Janni W, Kreienberg R, Blettner M, et al. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J. 2018;24:120\u20137.","journal-title":"Breast J"},{"key":"1680_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jclinepi.2007.02.013","volume":"60","author":"S Kropp","year":"2007","unstructured":"Kropp S, Terboven T, Hedicke J, Mutschelknauss E, Slanger T, Braendle W, et al. Good agreement between physician and self-reported hormone therapy data in a case-control study. J Clin Epidemiol. 2007;60:1280\u20137.","journal-title":"J Clin Epidemiol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-023-01680-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T07:06:06Z","timestamp":1690441566000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-023-01680-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1186\/s13058-023-01680-x","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent from all participants has been obtained. The MARIE study was approved by the ethics committees of the University of Heidelberg, the Hamburg Medical Council, and the Medical Board of the State of Rhineland-Palatinate and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}